通过多臂聚乙烯葡萄糖结合设计药用的生物活性特征
Haonan Chen1, Yuhang Dong1, Feng Shi2
1State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
Langmuir : the ACS journal of surfaces and colloids
|April 8, 2025
概括
多臂聚乙烯甘醇 (PEG) 修改梅利丁可显著降低毒性和溶血活性,同时提高血清稳定性. 这一策略通过改变膜相互作用并提供固体阻碍来提高类药物安全性和有效性.
科学领域:
- 生物医学工程 生物医学工程
- 药物运输 药物运输 药物运输
- 类治疗药物 类治疗药物
背景情况:
- 聚乙烯甘醇 (PEG) 化是生物医学中关键的改技术.
- 基化增强了类药物的性能,但多臂结构的影响需要进行系统的调查.
研究的目的:
- 合成和评估经不同数量的PEG臂 (单臂,双臂,四臂PEG12) 修改的梅利丁.
- 系统地研究多臂PEGylation对梅利丁毒性,血液溶解活性,稳定性和膜破坏的影响.
- 探索PEG拓在微调类药物特性中的作用.
主要方法:
- 使用lysine侧链合成具有单,双和四臂PEG12修饰的梅利丁.
- 系统评估细胞毒性,溶血活性,血清稳定性和破坏膜的能力.
- 基于PEG臂数和拓学的结构-活动关系分析.
主要成果:
- 增加PEG手臂显著降低了梅利丁的细胞毒性和溶血活性 (IC50增加了约20倍).
- 多臂PEGylation增强了梅利丁的血清稳定性.
- 降低的毒性和改变的膜相互作用归因于提高溶解度,改变的水友性/水性和固体阻碍.
结论:
- 多臂PEGylation,特别是终端PEGylation是一种可行的策略,以最大限度地降低药物的全身毒性和体内降解.
- PEG的拓结构极大地影响了的药物性能.
- 研究结果为设计更安全,更有效的基于的治疗方法提供了洞察力.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...